{
    "nctId": "NCT02151071",
    "briefTitle": "The Breast Surgery EnLight and LightPath Imaging System Study",
    "officialTitle": "A Pilot Study to Evaluate Molecular Imaging Using a BetaScope and a Specimen Analyser for Determining Margin and Lymph Node Status During Breast Conserving Surgery in Women With Breast Cancer",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 30,
    "primaryOutcomeMeasure": "Feasibility of intraoperative use of the EnLight and LightPath Imaging Systems.",
    "eligibilityCriteria": "Inclusion Criteria\n\nFemales \u2265 30 years of age with a diagnosis of invasive breast cancer or DCIS\n\nScheduled for BCS +/- SLNB or ALND\n\nFemales of childbearing age must have a negative pregnancy test (by Beta HCG qualitative analysis), must have a history of surgical sterilisation, or must give history of no menses in past twelve months\n\nExclusion Criteria\n\nSurgery or radiotherapy in the operated breast in the past 2 years\n\nNeoadjuvant systemic therapy\n\nPatients not suitable for BCS\n\nBlood glucose level \u2265 12 mmol/l on the day of surgery\n\nKnown hypersensitivity to 18F-FDG\n\nAny patient who is pregnant or lactating",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}